rts logo

Viking Therapeutics Inc (VKTX) – key numbers that make it a Strong Buy For Now

Viking Therapeutics Inc (NASDAQ: VKTX) is 315.64% higher on its value in year-to-date trading and has touched a low of $8.28 and a high of $99.41 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VKTX stock was last observed hovering at around $79.50 in the last trading session, with the day’s loss setting it -2.15%.

Currently trading at $77.35, the stock is 4.46% and 51.52% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.0 million and changing -2.70% at the moment leaves the stock 225.66% off its SMA200. VKTX registered 346.34% gain for a year compared to 6-month gain of 598.74%. The firm has a 200-day simple moving average (SMA200) of -$81.81.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The stock witnessed a -9.23% loss in the last 1 month and extending the period to 3 months gives it a 315.64%, and is 11.79% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.48% over the week and 9.53% over the month.

Viking Therapeutics Inc (VKTX) has around 27 employees, a market worth around $8.46B and $0.00M in sales. Distance from 52-week low is 834.18% and -22.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-24.59%).

Viking Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.28.The EPS is expected to shrink by -23.39% this year.

Viking Therapeutics Inc (VKTX) Top Institutional Holders

281 institutions hold shares in Viking Therapeutics Inc (VKTX), with institutional investors hold 77.94% of the company’s shares. The shares outstanding are 100.11M, and float is at 99.62M with Short Float at 11.18%. Institutions hold 73.69% of the Float.

The top institutional shareholder in the company is FMR, LLC with over 14.98 million shares valued at $242.76 million. The investor’s holdings represent 14.97% of the VKTX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 6.89 million shares valued at $111.77 million to account for 6.89% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 5.11 million shares representing 5.11% and valued at over $82.87 million, while State Street Corporation holds 4.82% of the shares totaling 4.82 million with a market value of $78.12 million.

Viking Therapeutics Inc (VKTX) Insider Activity

The most recent transaction is an insider sale by Lian Brian,the company’sPresident & CEO. SEC filings show that Lian Brian sold 45,000 shares of the company’s common stock on Feb 09 ’24 at a price of $29.90 per share for a total of $1.35 million. Following the sale, the insider now owns 2.14 million shares.

Viking Therapeutics Inc disclosed in a document filed with the SEC on Feb 08 ’24 that Lian Brian (President & CEO) sold a total of 269,079 shares of the company’s common stock. The trade occurred on Feb 08 ’24 and was made at $26.87 per share for $7.23 million. Following the transaction, the insider now directly holds 2.18 million shares of the VKTX stock.

Still, SEC filings show that on Feb 08 ’24, Rouan Sarah Kathryn (Director) disposed off 25,000 shares at an average price of $28.05 for $0.7 million. The insider now directly holds 0 shares of Viking Therapeutics Inc (VKTX).

Related Posts